Dr Stasa Stankovic is a world-leading scientist in reproductive medicine, holding a BSc from the University of Oxford and Oxford Brookes University, and an MPhil and PhD in Reproductive Genomics from the University of Cambridge. Her research contributed to the discovery of many of the first genetic determinants for infertility, menopause, and PCOS – revealing novel biological mechanisms that could serve as targets for therapeutic intervention. This work laid the foundation for launching OvartiX.
Stasa serves as a strategy consultant at AstraZeneca, where she is defining and scaling corporate-wide strategy on the application of human omics, AI, and machine learning in drug discovery. She is also a scientific advisor to Cercle AI, an AI-driven women’s health startup. Prior to founding OvartiX, she worked as an external consultant to McKinsey & Company, the Government of the Republic of Serbia, and numerous pharmaceutical companies.
In recognition of her work, she has received several notable awards: ‘McKinsey&Company Next Generation Women Leader’ for 2020, ‘Robert Greenblatt Award: the best young investigator under the age of 40’ by the International Menopause Society, one of ten best UK young scientists in the biomedical sector by the UK Government ‘STEM for Britain’, ‘One of top 100 UK women in tech’ by Barclays, ‘One of top 200 trailblazing women in women’s health and femtech’ by Covington and Women of Wearables, and she is considered as ‘one of 11 scientists with the highest impact on innovations in menopause and reproductive health’ by Forbes.